- This page, Board of Registration in Pharmacy (via Webex) — May 7, 2026, is offered by
- Board of Registration in Pharmacy
Public Meeting Notice Board of Registration in Pharmacy (via Webex) — May 7, 2026
Overview
This meeting will be by Webex Conference Call.
Join by the webinar link
- Webinar link: Meeting Link
- Meeting number: 2538 470 3456
- Webinar Password: BOP123
Join by telephone
- +1-617-315-0704 United States Toll (Boston)
- +1-650-479-3208 United States Toll
- Global call-in numbers | Toll-free calling restrictions
If you need reasonable accommodations in order to participate in the meeting, contact the DPH ADA Coordinator Stacy Hart, Stacy.Hart@mass.gov or 857-274-1120 in advance of the meeting. While the Board will do its best to accommodate you, certain accommodation may require distinctive requests or the hiring of outside contractors and may not be available if requested immediately before the meeting.
Agenda
| Time | Item # | Item | Staff Member | |||
|---|---|---|---|---|---|---|
| 8:00 | I | CALL TO ORDER | S. Dinno | |||
| 8:05 | II | APPROVAL OF AGENDA | ||||
| 8:10 | III | APPROVAL OF BOARD MINUTES •Draft of March 26, 2026, Regular Session Minutes | ||||
| 8:15 | IV | REPORTS
| ||||
| 8:30 | V | FLEX
|
| |||
| 8:45 | VI | APPLICATIONS
| ||||
| 9:30 | VII | HEARING ON DENIAL OF APPLICATION FOR A NON-RESIDENT RETAIL PHARMACY- STERILE COMPOUNDING LICENSE • Promise Pharmacy, NDS31881 Denial of application for non-resident retail pharmacy – sterile compounding license. (NDS31881SC) | ||||
| 10:00 | VIII | INVESTIGATIVE CONFERENCE •Drug Crafters, NDS31755; PHA-2025-0158 | ||||
| 10:30 | IX | FILE REVIEW | ||||
| 1 | CASE-2025-3610 | PHA-2025-0135 | Walgreens #3112, DS2798 | |||
| 2 | CASE-2025-3609 | PHA-2025-0139 | Walgreens #10318, DS89638 | |||
| 3 | CASE-2025-3875 | PHA-2025-0158 | Drug Crafters, NDS31755 | |||
| 4 | CASE-2026-0268 | PHA-2026-0021 | Prescription Center Pharmacy, DS89916 | |||
| 5 | CASE-2026-0507 | PHA-2026-0029 | Lifespan of Massachusetts-Fall River, Inc. d/b/a Brown University Health Cancer Institute at Foxboro, St. Anne's Hospital, IS21079 | |||
| 6 | CASE-2025-4244 | PHA-2026-0015 | Precision Medication INC. dba Precision Medicine, NDS31653 | |||
| 7 | CASE-2026-0534 | PHA-2026-0038 | American Life Pharmacy, NDS31969 | |||
| 8 | CASE-2025-4243 | PHA-2026-0012 | Revive Rx , NDS31277 | |||
| 9 | CASE-2026-0608 | PHA-2026-0042 | Imprimis NJOF, LLC, NO00040 | |||
| 10 | CASE-2025-3670 | PHA-2025-0143 | Walgreens #17650, DS90229 | |||
| 11 | CASE-2025-3963 | PHA-2025-0159 | Walgreens #11120, DS89681 | |||
| 12 | CASE-2025-4058 | PHA-2025-0166 | Star Market Pharmacy #3577, DS3163 | |||
| 13 | CASE-2025-3504 | PHA-2025-0130 | CVS #1866, DS2956 | |||
| 14 | CASE-2025-3602 | PHA-2025-0134 | CVS #1249, DS2688 | |||
| 15 | CASE-2026-0009 | PHA-2026-0007 | CVS #5464, DS89826 | |||
| 16 | CASE-2026-0047 | PHA-2026-0014 | CVS #5464, DS89826 | |||
| 11:30 | X | EXECUTIVE SESSION The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant and to conduct a hearing regarding a license denial. | ||||
| 12:30 | LUNCH BREAK | |||||
| 1:00 | XI | ADJUDICATORY SESSION (M.G.L. c. 30A, § 18) | ||||
| 1:15 | XII | M.G.L. c. 112, § 65C SESSION | ||||
| 4:00 | ADJOURNMENT | |||||